Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. PMV Pharmaceuticals Inc shares valued at $195,763 were sold by ORBIMED ADVISORS LLC on Nov 22 ’23. At $2.23 per share, ORBIMED ADVISORS LLC sold 87,786 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion of this transaction.
Also, Alland Leila sold 6,291 shares, netting a total of over 41,646 in proceeds. Following the sale of shares at $6.62 each, the insider now holds 45,909 shares.
Before that, Jalota Deepika had sold 4,104 shares from its account. In a trade valued at $27,168, the Chief Development Officer traded PMV Pharmaceuticals Inc shares for $6.62 each. Upon closing the transaction, the insider’s holdings decreased to 4,104 shares, worth approximately $55699.560000000005.
As published in their initiating research note from Jefferies on April 12, 2024, PMV Pharmaceuticals Inc [PMVP] has been a Buy and the price target has been revised to $5. Analysts at Ladenburg Thalmann started covering the stock with ‘”a Buy”‘ outlook in a report released in late December. As of March 02, 2022, Oppenheimer has increased its “Perform” rating to a “an Outperform” for PMVP. Earlier on September 22, 2021, Goldman upgraded its rating. Their new recommendation was “a Buy” for PMVP stock which previously was a “a Neutral”.
Analyzing PMVP Stock Performance
During the last five days, there has been a surge of approximately 10.06%. Over the course of the year, PMV Pharmaceuticals Inc shares have dropped approximately -40.00%. Shares of the company reached a 52-week high of $3.4700 on 01/02/24 and a 52-week low of $1.4600 on 02/14/24. A 50-day SMA is recorded $1.7133, while a 200-day SMA reached $3.4165. Nevertheless, trading volume fell to 0.43 million shares from 0.22 million shares the previous day.
Support And Resistance Levels for PMV Pharmaceuticals Inc (PMVP)
According to the 24-hour chart, there is a support level at 1.8167, which, if violated, would cause prices to drop to 1.7733. In the upper region, resistance lies at 1.8917. The next price resistance is at 1.9233. RSI (Relative Strength Index) is 60.38 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.0971, which suggests the price will decrease in the coming days. Percent R is at 6.45%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
